Estudo avaliará segurança e resposta imunológica em 50 adultos saudáveis entre 18 e 55 anos

La investigación ha pasado ya la fase inicial experimental en ratones y supone una alternativa más sencilla ante el virus más común de esta enfermedad, al no depender de cadenas…

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleThe University of Oxford is set to begin…

The jab could be ready to send to the Democratic Republic of Congo within weeks

Estudo avaliará segurança e resposta imunológica em 50 adultos saudáveis entre 18 e 55 anos

Oxford begins first human trial of vaccine targeting Bundibugyo Ebola strain

Oxford Vaccine Group initiates the first Phase I trial for Bundibugyo ebolavirus vaccine with support from India's Serum Institute.